{"id":"NCT01412281","sponsor":"Crucell Holland BV","briefTitle":"Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers","officialTitle":"Randomized, Parallel-group, Double-blind, Single-center Phase III Study to Assess the Immunogenicity and Safety of the 2011/2012-season Influenza Vaccine Formulated With HA Antigen From Two Suppliers, in Elderly and Young Adult Subjects Using the Current EMA Regulations as Guideline","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2011-08-09","resultsPosted":"2013-03-22","lastUpdate":"2013-09-09"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Virosomal influenza vaccine (AdImmune HA Antigen)","otherNames":[]},{"type":"BIOLOGICAL","name":"Virosomal influenza vaccine (CSL HA Antigen)","otherNames":[]}],"arms":[{"label":"Group A - Young adults","type":"EXPERIMENTAL"},{"label":"Group B - Young adults","type":"ACTIVE_COMPARATOR"},{"label":"Group C - Elderly","type":"EXPERIMENTAL"},{"label":"Group D - Elderly","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal V using two different HA antigen suppliers (AdImmune and CSL), in groups of young and elderly adults, using the EMA (European Medicines Agency) regulation as a guideline.","primaryOutcome":{"measure":"Geometric Mean Titer","timeFrame":"3 weeks after vaccination (Day 22 ± 2 days)","effectByArm":[{"arm":"≥18 to ≤60 Years - AdImmune HA Antigen","deltaMin":3.36,"sd":null},{"arm":"≥18 to ≤60 Years - CSL HA Antigen","deltaMin":2.61,"sd":null},{"arm":">60 Years - AdImmune HA Antigen","deltaMin":2.46,"sd":null},{"arm":">60 Years - CSL HA Antigen","deltaMin":2.41,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":1,"countries":["Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":110},"commonTop":["Pain (at the injection site)","Erythema (at the injection site)","Headache","Induration (at the injection site)","Malaise"]}}